Home > Journals > Acta Pharmaceutica Sinica >Issue 04,2020
Acta Pharmaceutica Sinica
Translated from the Chinese edition
Supervisor(s): The China Association for Science and Technology
Sponsor(s): Chinese Pharmaceutical Association
ISSN:0513-4870 CN:11-2163/R

12 issues per year

Current Issue: Issue 04, 2020  

Total Downloads:68

  • Acta Pharmaceutica Sinica, Launched in July 1953, it is supervised by China Association for Science and Technology and sponsored by Chinese Pharmaceutical Association. Its editorial board is composed of 120 well-known pharmaceutical experts at home and abroad, including 9 academicians, 9 foreign member experts. It is devoted to original research articles on pharmaceutical sciences including pharmacology, toxicology, pharmacy, pharmacognosy, antibiotics, chemistry of natural products, pharmaceutical chemistry and pharmaceutical analysis. Research articles, communications, reviews and commentaries introducing new theories and technologies. Readers of Acta Pharmaceutica Sinica are mainly those involved in scientific research and those pertaining to higher education. The journal is included in CA, JST, Pж(AJ), CSCD.

  • Honorary Editor-in-Chief
    Sang Guowei;Zhou Tonghui

    Editor-in-Chief
    Wang Xiaoliang

    Deputy Editor-in-Chief
    Bi Kaishun;Chen Shilin
    Chen Kaixian;Ding Jian
    Guo Zongru;Jiang Jiandong
    Yang Baofeng;Yu Dequan
    Zhang Qiang;Zheng Ailian

Progress on anti-IFV drug targets and small molecule inhibitors

XIU Si-yu;ZHANG Jian;JU Han;JIA Rui-fang;HUANG Bing;ZHAN Peng;LIU Xin-yong

Acta Pharmaceutica Sinica,2020,Vol 55,No. 04

Recent advances in the research of broad-spectrum antiviral agents

HUANG Tian-guang;SUN Lin;ZHAN Peng;LIU Xin-yong

Acta Pharmaceutica Sinica,2020,Vol 55,No. 04

Medicinal chemistry strategies in seeking coronavirus inhibitors

LI Jing;JIANG Xiang-yi;XU Shu-jing;CUI Qing-hua;DU Rui-kun;KANG Dong-wei;ZHAN Peng;RONG Li-jun;LIU Xin-yong

Acta Pharmaceutica Sinica,2020,Vol 55,No. 04